128 related articles for article (PubMed ID: 28636124)
21. A comparison study of complications and initial follow-up costs of transcutaneous and percutaneous bone conduction devices.
Godbehere J; Carr SD; Moraleda J; Edwards P; Ray J
J Laryngol Otol; 2017 Aug; 131(8):667-670. PubMed ID: 28625187
[TBL] [Abstract][Full Text] [Related]
22. Subdural Hematoma: A Rare Adverse Complication From Bone-Anchored Hearing Aid Placement.
Amin N; Aymat-Torrente A
Otol Neurotol; 2017 Mar; 38(3):360-363. PubMed ID: 28114179
[TBL] [Abstract][Full Text] [Related]
23. Z-plasty for skin complications of bone-anchored hearing aid implantation.
Miura MS; Rios MN
J Laryngol Otol; 2015 Jun; 129(6):604-6. PubMed ID: 26074260
[TBL] [Abstract][Full Text] [Related]
24. Comparison between a new implantable transcutaneous bone conductor and percutaneous bone-conduction hearing implant.
Hol MK; Nelissen RC; Agterberg MJ; Cremers CW; Snik AF
Otol Neurotol; 2013 Aug; 34(6):1071-5. PubMed ID: 23598702
[TBL] [Abstract][Full Text] [Related]
25. Skin and soft tissue complications of bone-anchored hearing aids: Introducing a new classification system.
Costa JR; Costa S; Soares T; Feliciano T; Almeida E Sousa C; Coutinho MB
Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(2):85-92. PubMed ID: 37005042
[TBL] [Abstract][Full Text] [Related]
26. [Prevention and treatment of skin complications following BAHA implantation].
Fan Y; Zhang Y; Wang Z; Wang P; Zhu XL; Yang H; Chen XW; Gao ZQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Oct; 48(10):798-801. PubMed ID: 24406174
[TBL] [Abstract][Full Text] [Related]
27. Canal atresia: "surgery or implantable hearing devices? The expert's question is revisited".
Evans AK; Kazahaya K
Int J Pediatr Otorhinolaryngol; 2007 Mar; 71(3):367-74. PubMed ID: 17196671
[TBL] [Abstract][Full Text] [Related]
28. Bone-anchored hearing aid surgery in older adults: implant loss and skin reactions.
de Wolf MJ; Hol MK; Mylanus EA; Cremers CW
Ann Otol Rhinol Laryngol; 2009 Jul; 118(7):525-31. PubMed ID: 19708493
[TBL] [Abstract][Full Text] [Related]
29. Implantable hearing devices.
Jones S; Harris D; Estill A; Mikulec AA
Mo Med; 2008; 105(3):235-9. PubMed ID: 18630303
[TBL] [Abstract][Full Text] [Related]
30. The Bonebridge: preclinical evaluation of a new transcutaneously-activated bone anchored hearing device.
Huber AM; Sim JH; Xie YZ; Chatzimichalis M; Ullrich O; Röösli C
Hear Res; 2013 Jul; 301():93-9. PubMed ID: 23467173
[TBL] [Abstract][Full Text] [Related]
31. Amplification of transcutaneous and percutaneous bone-conduction devices with a test-band in an induced model of conductive hearing loss.
Park MJ; Lee JR; Yang CJ; Yoo MH; Jin IS; Choi CH; Park HJ
Int J Audiol; 2016 Nov; 55(11):653-7. PubMed ID: 27347717
[TBL] [Abstract][Full Text] [Related]
32. Bone-anchored hearing aid implant location in relation to skin reactions.
Faber HT; de Wolf MJ; de Rooy JW; Hol MK; Cremers CW; Mylanus EA
Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):742-7. PubMed ID: 19687391
[TBL] [Abstract][Full Text] [Related]
33. Laser-Doppler microvascular measurements in the peri-implant areas of different osseointegrated bone conductor implant systems.
Jarabin J; Bere Z; Hartmann P; Tóth F; Kiss JG; Rovó L
Eur Arch Otorhinolaryngol; 2015 Dec; 272(12):3655-62. PubMed ID: 25502915
[TBL] [Abstract][Full Text] [Related]
34. A Systematic Review on Complications of Tissue Preservation Surgical Techniques in Percutaneous Bone Conduction Hearing Devices.
Verheij E; Bezdjian A; Grolman W; Thomeer HG
Otol Neurotol; 2016 Aug; 37(7):829-37. PubMed ID: 27273402
[TBL] [Abstract][Full Text] [Related]
35. Bone conduction implants for amplification: comparison of results.
Hough DA; Matthews P; Hough JV
Ear Nose Throat J; 1997 Dec; 76(12):857, 861-2, 864-5. PubMed ID: 9431774
[TBL] [Abstract][Full Text] [Related]
36. Skin reactions after BAHA surgery: a comparison between the U-graft technique and the BAHA dermatome.
Stalfors J; Tjellström A
Otol Neurotol; 2008 Dec; 29(8):1109-14. PubMed ID: 18758391
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of skin complications between dermatome and U-graft technique in BAHA surgery].
Tamarit Conejeros JM; Dalmau Galofre J; Murcia Puchades V; Pons Rocher F; Fernández Martínez S; Estrems Navas P
Acta Otorrinolaringol Esp; 2009; 60(6):422-7. PubMed ID: 19909718
[TBL] [Abstract][Full Text] [Related]
38. Three-week loading of the 4.5mm wide titanium implant in bone anchored hearing systems.
Wazen JJ; Babu S; Daugherty J; Metrailer A
Am J Otolaryngol; 2016; 37(2):132-5. PubMed ID: 26954868
[TBL] [Abstract][Full Text] [Related]
39. International consensus on Vibrant Soundbridge® implantation in children and adolescents.
Cremers CW; O'Connor AF; Helms J; Roberson J; Clarós P; Frenzel H; Profant M; Schmerber S; Streitberger C; Baumgartner WD; Orfila D; Pringle M; Cenjor C; Giarbini N; Jiang D; Snik AF
Int J Pediatr Otorhinolaryngol; 2010 Nov; 74(11):1267-9. PubMed ID: 20828837
[TBL] [Abstract][Full Text] [Related]
40. UK and Ireland experience of bone anchored hearing aids (BAHA) in individuals with Down syndrome.
Sheehan PZ; Hans PS
Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):981-6. PubMed ID: 16310862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]